This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Lifetime Impact of Achondroplasia Study in Europe-LIAISE

Sponsored by BioMarin Pharmaceutical

About this trial

Last updated 4 years ago

Study ID

111-501

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
5 to 70 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 5 years ago

What is this trial about?

Observational study looking at the burden of illness in achondroplasia subjects aged 5-70. The study will include a 5 year review of historical clinical data as well as a single point collection of questionnaire data to look at the impact on the following in individuals with achondroplasia versus a normative population: - Quality of life - Clinical burden - Healthcare resource use - Socio-economic burden - Psychosocial burden Up to 300 subjects will be included in sites in Germany, Spain, Italy, Sweden, Austria and Denmark

What are the participation requirements?

Yes

Inclusion Criteria

1. Individuals with a documented diagnosis of achondroplasia based on:

1. Genetic confirmation of achondroplasia and/or
2. Clinical diagnosis of achondroplasia (clinical examination or radiological assessment)

2. ≥ five years of age at the time of enrolment

3. Has the cognitive and linguistic capacities necessary to complete questionnaires in the language of his/her country (and/or parents/legally acceptable representatives, as applicable)

4. Agrees to participate in the study and has read, understood, completed and signed:

1. Informed Consent Form (ICF) - for adult subjects
2. Informed Assent Form (IAF) - for minor subjects, accompanied by a parental ICF completed by their parents/legally acceptable representatives. The age at which the minor subjects sign the IAF will be subject to local requirements.

5. Has medical records available for at least the five years prior to the date of enrolment.

No

Exclusion Criteria

1. Currently participating, or participated within the last six months, in

1. a clinical trial of a medicinal product or medical device or,
2. other non-clinical, low interventional studies

2. Currently participating or participated in any BioMarin study at any time.

Locations

Location

Status